Pediatric Atrial Ectopic Tachycardia Workup

  • Author: Shubhayan Sanatani, MD; Chief Editor: Stuart Berger, MD   more...
 
Updated: Mar 29, 2011
 

Approach Considerations

During the arrhythmia in stable patients, 12-lead electrocardiography (ECG) is necessary. Laboratory testing is indicated for the exclusion of underlying systemic disorders. Echocardiography and Holter monitoring are also part of the standard workup. Electrophysiology testing may be useful in some patients. Exercise testing may occasionally unmask an intermittent atrial ectopic tachycardia (AET).

Go to Atrial Tachycardia and Multifocal Atrial Tachycardia for information on these topics.

Exclusion of systemic disorders

  • Assess electrolyte levels, hematocrit levels, and thyroid function in patients with atrial ectopic tachycardia.
  • Consider thyroid studies.
  • Consider urine collections in some patients for assessment of possible pheochromocytoma.
Next

Electrocardiography

Inspect the electrocardiogram (ECG) for P-wave axis and morphology, ventricular rate, and conduction block.

The diagnosis of atrial ectopic tachycardia is based on the presence of a narrow complex tachycardia (in the absence of aberrancy or preexisting bundle branch block) with visible P waves at an inappropriately rapid rate. The rates range from 120 to 300 beats per minute (bpm) and are typically higher than 200 bpm, although physiologic rates may be observed.

The P-wave axis is usually abnormal, although a focus near the sinus node can be mistaken for sinus tachycardia. Similarly, the P-wave morphology may be abnormal. Onset of the tachycardia occurs with a P wave identical to the subsequent P waves. The tachycardia may exhibit a "warming up," which refers to a progressively shortening P-P interval for the first few beats of the arrhythmia. Similarly, a "cooling down" may be observed at its termination. First-degree atrioventricular (AV) block is typical and second-degree AV block is common. The tachycardia cycle length and degree of AV block are influenced by the autonomic tone.

Ectopic atrial tachycardia usually creates a P wave that is at least slightly different from sinus rhythm, first-degree atrioventricular (AV) block, and possible periods of second-degree AV block without termination of tachycardia.

To differentiate atrial ectopic tachycardia from sinus tachycardia secondary to cardiomyopathy, Gelb and Garson demonstrated that negative late terminal P-wave forces in lead V2 occur more commonly in atrial ectopic tachycardia.[4] The rate is also usually higher in atrial ectopic tachycardia.

Algorithms to determine the site of the ectopic focus based on P-wave morphology are known. A negative or biphasic (positive, then negative) P wave in lead V1 indicated a right atrial tachycardia. A positive or biphasic (negative, then positive) P wave in ECG lead V1 indicated a left atrial tachycardia.[5]

Previous
Next

Holter Monitoring

Patients should undergo Holter monitoring to determine the time spent in tachycardia and the ventricular rates. Holter monitoring is particularly useful in identifying and analyzing onsets and offsets of tachycardia.

The Holter monitor findings often facilitate the diagnosis by revealing: (1) an elevated average heart rate over a 24-hour period, with reduced circadian variability; (2) a higher peak heart rate than normally encountered in sinus rhythm; or (3) periods of atrioventricular (AV) block, demonstrating 2 consecutive P waves at an elevated rate without an intervening QRS complex.

Previous
Next

Echocardiography

Perform echocardiography with a focus on cardiac function and dimensions to rule out cardiomyopathy and associated congenital heart disease. The earliest manifestation of cardiomyopathy may be ventricular dilatation. A decreased shortening fraction follows. Reversal of these findings after treatment follows a reciprocal pattern. Diastolic function abnormalities may also occur in tachycardia-induced cardiomyopathy, and they may be the last parameter to correct after therapy.

Previous
Next

Angiography

Atrial angiography may occasionally be helpful as a roadmap during radiofrequency (RF) catheter ablation.

Previous
Next

Electrophysiology Studies

Although invasive studies are not usually necessary to make a diagnosis of atrial ectopic tachycardia, in some patients, an esophageal electrophysiology recording may be useful to assist confirmation of the diagnosis; the response to overdrive pacing can also be assessed. Many automatic foci transiently suppress when overdrive pacing is performed.

An invasive electrophysiology study can also be performed for these indications, but this is usually performed in patients undergoing attempt at radiofrequency (RF) ablation.

In patients with ectopic atrial tachycardias arising from the pulmonary veins, an esophageal recording may also be helpful in localizing the site of tachycardia.

The response of atrial ectopic tachycardia to adenosine may be persistent in the setting of atrioventricular (AV) block or a transient slowing of the tachycardia; it rarely terminates. Direct current (DC) cardioversion usually does not terminate the arrhythmia.

Previous
Next

Histologic Findings

Endomyocardial biopsy findings often reveal vacuolized myocytes in the setting of tachycardia-induced cardiomyopathy.

Previous
 
 
Contributor Information and Disclosures
Author

Shubhayan Sanatani, MD  Associate Professor, Department of Pediatrics, University of British Columbia Faculty of Medicine; Consulting Staff, Division of Pediatric Cardiology, British Columbia Children's Hospital, Canada

Shubhayan Sanatani, MD is a member of the following medical societies: British Columbia Medical Association, Canadian Cardiovascular Society, Canadian Heart Rhythm Society, Canadian Heart Rhythm Society, Canadian Medical Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Coauthor(s)

Robert Murray Hamilton, MD, MSc, FRCPC  Section Head, Electrophysiology, Director, High-Risk Hereditary Heart Conditions Clinic, Labatt Family Heart Centre; Professor, Department of Pediatrics, Associate Scientist, Physiology and Experimental Medicine, The Hospital for Sick Children and Research Institute, University of Toronto Faculty of Medicine, Canada

Robert Murray Hamilton, MD, MSc, FRCPC is a member of the following medical societies: American Heart Association, Canadian Cardiovascular Society, Canadian Medical Association, Canadian Medical Protective Association, Cardiac Electrophysiology Society, Heart Rhythm Society, Ontario Medical Association, Pediatric Electrophysiology Society, Royal College of Physicians and Surgeons of Canada, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Specialty Editor Board

Charles I Berul, MD  Professor of Pediatrics and Integrative Systems Biology, George Washington University School of Medicine; Chief, Division of Cardiology, Children's National Medical Center

Charles I Berul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, Pediatric and Congenital Electrophysiology Society, and Society for Pediatric Research

Disclosure: Johnson & Johnson Consulting fee Consulting

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Hugh D Allen, MD  Professor, Department of Pediatrics, Division of Pediatric Cardiology and Department of Internal Medicine, Ohio State University College of Medicine

Hugh D Allen, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, American Society of Echocardiography, Society for Pediatric Research, Society of Pediatric Echocardiography, and Western Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD  Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin

Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

References
  1. Dagres N, Gutersohn A, Wieneke H, Sack S, Erbel R. A new hereditary form of ectopic atrial tachycardia with autosomal dominant inheritance. Int J Cardiol. Feb 2004;93(2-3):311-3. [Medline].

  2. Bauersfeld U, Gow RM, Hamilton RM, Izukawa T. Treatment of atrial ectopic tachycardia in infants < 6 months old. Am Heart J. Jun 1995;129(6):1145-8. [Medline].

  3. Salerno JC, Kertesz NJ, Friedman RA, Fenrich AL Jr. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children or =3 years of age. J Am Coll Cardiol. Feb 4 2004;43(3):438-44. [Medline].

  4. Gelb BD, Garson A Jr. Noninvasive discrimination of right atrial ectopic tachycardia from sinus tachycardia in "dilated cardiomyopathy". Am Heart J. 1990;120:886-91. [Medline].

  5. Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol. Sep 5 2006;48(5):1010-7. [Medline].

  6. Higa S, Tai CT, Lin YJ, et al. Focal atrial tachycardia: new insight from noncontact mapping and catheter ablation. Circulation. Jan 6 2004;109(1):84-91. [Medline]. [Full Text].

  7. Liew R, Catanchin A, Behr ER, Ward D. Use of non-contact mapping in the treatment of right atrial tachycardias in patients with and without congenital heart disease. Europace. Aug 2008;10(8):972-81. [Medline].

  8. Cummings RM, Mahle WT, Strieper MJ, Campbell RM, Costello L, Balfour V. Outcomes following electroanatomic mapping and ablation for the treatment of ectopic atrial tachycardia in the pediatric population. Pediatr Cardiol. Mar 2008;29(2):393-7. [Medline].

  9. Haas NA, Fox S, Skinner JR. Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias. Cardiol Young. Aug 2005;15(4):427-30. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.